112 related articles for article (PubMed ID: 8654872)
1. Glucocorticoid receptor-activator protein-I interactions in drug design.
Wade EJ; Heck S; Cato AC
Biochem Soc Trans; 1995 Nov; 23(4):946-52. PubMed ID: 8654872
[No Abstract] [Full Text] [Related]
2. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently.
Gougat C; Jaffuel D; Gagliardo R; Henriquet C; Bousquet J; Demoly P; Mathieu M
J Mol Med (Berl); 2002 May; 80(5):309-18. PubMed ID: 12021843
[TBL] [Abstract][Full Text] [Related]
3. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
4. Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/activator protein-1 elements.
Smith PJ; Cousins DJ; Jee YK; Staynov DZ; Lee TH; Lavender P
J Immunol; 2001 Sep; 167(5):2502-10. PubMed ID: 11509589
[TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanism of glucocorticoid action].
Grzanka A; Jarzab J; Rogala B
Pol Arch Med Wewn; 1996 Apr; 95(4):375-82. PubMed ID: 8755845
[No Abstract] [Full Text] [Related]
6. Homologous down-regulation of the glucocorticoid receptor down-modulates cellular hormone responsiveness in human histiocytic lymphoma U937 cells.
Fukawa E; Tanaka H; Makino Y; Hirano F; Akama H; Kawai S; Makino I
Endocr J; 1994 Dec; 41(6):623-30. PubMed ID: 7704085
[TBL] [Abstract][Full Text] [Related]
7. [Canonical and Noncanonical Mechanisms of Glucocorticoid Stress Hormones Action].
Usp Fiziol Nauk; 2016; 47(3):59-69. PubMed ID: 29283230
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.
Cha HJ; Park MT; Chung HY; Kim ND; Sato H; Seiki M; Kim KW
Oncogene; 1998 Feb; 16(6):771-8. PubMed ID: 9488041
[TBL] [Abstract][Full Text] [Related]
9. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.
De Bosscher K; Vanden Berghe W; Haegeman G
Endocr Rev; 2003 Aug; 24(4):488-522. PubMed ID: 12920152
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor function and clinical medicine.
Luft FC
J Mol Med (Berl); 2002 May; 80(5):267-9. PubMed ID: 12021837
[No Abstract] [Full Text] [Related]
11. Molecular mechanisms of glucocorticoid action and resistance.
Schaaf MJ; Cidlowski JA
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):37-48. PubMed ID: 12650700
[TBL] [Abstract][Full Text] [Related]
12. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
13. Extreme position dependence of a canonical hormone response element.
Nordeen SK; Ogden CA; Taraseviciene L; Lieberman BA
Mol Endocrinol; 1998 Jun; 12(6):891-8. PubMed ID: 9626664
[TBL] [Abstract][Full Text] [Related]
14. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
Chu S; Nishi Y; Yanase T; Nawata H; Fuller PJ
Mol Endocrinol; 2004 Aug; 18(8):1919-28. PubMed ID: 15155785
[TBL] [Abstract][Full Text] [Related]
15. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness.
Bantel H; Schmitz ML; Raible A; Gregor M; Schulze-Osthoff K
FASEB J; 2002 Nov; 16(13):1832-4. PubMed ID: 12223450
[TBL] [Abstract][Full Text] [Related]
16. Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response.
Adcock IM; Cosio B; Tsaprouni L; Barnes PJ; Ito K
Antioxid Redox Signal; 2005; 7(1-2):144-52. PubMed ID: 15650403
[TBL] [Abstract][Full Text] [Related]
17. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
18. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.
Vayssière BM; Dupont S; Choquart A; Petit F; Garcia T; Marchandeau C; Gronemeyer H; Resche-Rigon M
Mol Endocrinol; 1997 Aug; 11(9):1245-55. PubMed ID: 9259316
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia.
Tissing WJ; Meijerink JP; den Boer ML; Pieters R
Leukemia; 2003 Jan; 17(1):17-25. PubMed ID: 12529655
[TBL] [Abstract][Full Text] [Related]
20. [The role of AP-1 and NF-kappaB in glucocorticoid resistance].
Okabe T; Yanase T; Nawada H
Nihon Rinsho; 2005 Sep; 63(9):1654-9. PubMed ID: 16164226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
